West Pharmaceutical Services Inc. Stock Underperforms Thursday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.West Pharmaceutical Services (WST) shares fell 1.74% to $346.16 on Thursday, underperforming the broader market and key competitors like Abbott Laboratories and Baxter International. The stock closed 10.32% below its 52-week high of $386.00. Trading volume was slightly below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of West Pharmaceutical Services Inc. (WST) slid 1.74% to $346.16 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.65% to 7,798.99 and the Dow Jones Industrial Average rising 0.13% to 53,839.99.
West Pharmaceutical Services Inc. closed 10.32% below its 52-week high of $386.00, which the company achieved on July 23rd.
The stock underperformed when compared to some of its competitors Thursday, as Abbott Laboratories (ABT) rose 0.32% to $111.27, Becton Dickinson & Co. (BDX) fell 0.88% to $181.97, and Baxter International Inc. (BAX) rose 0.37% to $27.05.
Trading volume (768,723) remained 7,816 below its 50-day average volume of 776,539.
Data source: Dow Jones Market Data, FactSet. Data compiled August 13, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-13-26 1704ET